nach oben

Erschienen in:

18.07.2019 | Original Article

Inhibition of Fibroblast Growth Factor Receptor by AZD4547 Protects Against Inflammation in Septic Mice

verfasst von: Yueyue Huang, Fen Wang, Hao Li, ShunYao Xu, Wenwei Xu, XiaoJun Pan, Yufeng Hu, Lingjie Mao, Songzan Qian, Jingye Pan

Erschienen in: Inflammation | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Sepsis is a life-threatening condition caused by the dysregulated host immune response to infection characterized by excessive secretion of inflammatory factors. AZD4547 is a selective inhibitor of fibroblast growth factor receptors that participates in the inflammatory response. The aim of this study was to investigate the inflammation-targeting effects and related molecular mechanisms of AZD4547 in sepsis using a cecal ligation and puncture model and RAW264.7 macrophages stimulated with lipopolysaccharide. AZD4547 improved the survival of CLP mice and exhibited a robust protective function against lung damage histologically. Pretreatment with AZD4547 significantly alleviated the expression of the pro-inflammatory factors IL-1β, IL-6, TNF-α, MMP9, and CXCL10 both in vivo and in vitro. In addition, AZD4547 suppressed the proliferative activity of macrophages in lung tissue and RAW264.7 macrophages. In addition, the LPS-induced phosphorylation of key proteins of NF-κB/MAPK/STAT3 pathways in RAW264.7 macrophages, such as p65, IκB-α, Erk1/2, JNK, and STAT3 proteins, could be inhibited by AZD4547 pretreatment. In conclusion, AZD4547 exerts a protective effect against excessive inflammatory damage in septic mice and may have the potential for use as an effective drug for the management of sepsis.

Nur mit Berechtigung zugänglich

Fleischmann, C., A. Scherag, N.K. Adhikari, C.S. Hartog, T. Tsaganos, P. Schlattmann, D.C. Angus, K. Reinhart, and Trialists International Forum of Acute Care. 2016. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. American Journal of Respiratory and Critical Care Medicine 193 (3): 259–272. https://doi.org/10.1164/rccm.201504-0781OC.CrossRefPubMed

Rahmel, T. 2018. SSC international guideline 2016 - management of sepsis and septic shock. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 53 (2): 142–148. https://doi.org/10.1055/s-0043-114639. CrossRefPubMed

Chousterman, B.G., F.K. Swirski, and G.F. Weber. 2017. Cytokine storm and sepsis disease pathogenesis. Seminars in Immunopathology 39 (5): 517–528. https://doi.org/10.1007/s00281-017-0639-8.CrossRefPubMed

Gavine, P.R., L. Mooney, E. Kilgour, A.P. Thomas, K. Al-Kadhimi, S. Beck, C. Rooney, et al. 2012. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Research 72 (8): 2045–2056. https://doi.org/10.1158/0008-5472.CAN-11-3034.CrossRefPubMed

Fitzpatrick, E.A., X. Han, Z. Xiao, and L.D. Quarles. 2018. Role of fibroblast growth Factor-23 in innate immune responses. Front Endocrinol (Lausanne) 9: 320. https://doi.org/10.3389/fendo.2018.00320.CrossRef

Han, X., L. Li, J. Yang, G. King, Z. Xiao, and L.D. Quarles. 2016. Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages. FEBS Letters 590 (1): 53–67. https://doi.org/10.1002/1873-3468.12040.CrossRefPubMedPubMedCentral

Paik, P.K., R. Shen, M.F. Berger, D. Ferry, J.C. Soria, A. Mathewson, C. Rooney, N.R. Smith, M. Cullberg, E. Kilgour, D. Landers, P. Frewer, N. Brooks, and F. André. 2017. A phase Ib open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers. Clinical Cancer Research 23 (18): 5366–5373. https://doi.org/10.1158/1078-0432.CCR-17-0645.CrossRefPubMedPubMedCentral

Jang, J., H.K. Kim, H. Bang, S.T. Kim, S.Y. Kim, S.H. Park, H.Y. Lim, W.K. Kang, J. Lee, and K.M. Kim. 2017. Antitumor effect of AZD4547 in a fibroblast growth factor receptor 2-amplified gastric cancer patient-derived cell model. Translational Oncology 10 (4): 469–475. https://doi.org/10.1016/j.tranon.2017.03.001.CrossRefPubMedPubMedCentral

Dejager, L., I. Pinheiro, E. Dejonckheere, and C. Libert. 2011. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends in Microbiology 19 (4): 198–208. https://doi.org/10.1016/j.tim.2011.01.001.CrossRefPubMed

10.

Smith, K.M., J.D. Mrozek, S.C. Simonton, D.R. Bing, P.A. Meyers, J.E. Connett, and M.C. Mammel. 1997. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Critical Care Medicine 25 (11): 1888–1897.CrossRef

11.

Davies, L.C., M. Rosas, P.J. Smith, D.J. Fraser, S.A. Jones, and P.R. Taylor. 2011. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. European Journal of Immunology 41 (8): 2155–2164. https://doi.org/10.1002/eji.201141817.CrossRefPubMed

12.

Oeckinghaus, A., M.S. Hayden, and S. Ghosh. 2011. Crosstalk in NF-kappaB signaling pathways. Nature Immunology 12 (8): 695–708. https://doi.org/10.1038/ni.2065.CrossRefPubMed

13.

Ivashkiv, L.B. 2011. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. European Journal of Immunology 41 (9): 2477–2481. https://doi.org/10.1002/eji.201141783.CrossRefPubMedPubMedCentral

14.

Moreno, R.P., B. Metnitz, L. Adler, A. Hoechtl, P. Bauer, P.G. Metnitz, and Saps Investigators. 2008. Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Medicine 34 (3): 496–504. https://doi.org/10.1007/s00134-007-0943-1.CrossRefPubMed

15.

Linder, A., and J.A. Russell. 2014. An exciting candidate therapy for sepsis: Ulinastatin, a urinary protease inhibitor. Intensive Care Medicine 40 (8): 1164–1167. https://doi.org/10.1007/s00134-014-3366-9.CrossRefPubMed

16.

Kumar, V. 2018. Targeting macrophage immunometabolism: dawn in the darkness of sepsis. International Immunopharmacology 58: 173–185. https://doi.org/10.1016/j.intimp.2018.03.005.CrossRefPubMed

17.

Cavaillon, J.M., and M. Adib-Conquy. 2005. Monocytes/macrophages and sepsis. Critical Care Medicine 33 (12 Suppl): S506–S509.CrossRef

18.

Weber, G.F., and F.K. Swirski. 2014. Immunopathogenesis of abdominal sepsis. Langenbeck's Archives of Surgery 399 (1): 1–9. https://doi.org/10.1007/s00423-013-1129-7.CrossRefPubMed

19.

Helming, L. 2011. Inflammation: cell recruitment versus local proliferation. Current Biology 21 (14): R548–R550. https://doi.org/10.1016/j.cub.2011.06.005.CrossRefPubMed

20.

Punyadeera, C., E.M. Schneider, D. Schaffer, H.Y. Hsu, T.O. Joos, F. Kriebel, M. Weiss, and W.F. Verhaegh. 2010. A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity. Journal of Emergencies, Trauma, and Shock 3 (1): 26–35. https://doi.org/10.4103/0974-2700.58666. CrossRefPubMedPubMedCentral

21.

Herzig, D.S., L. Luan, J.K. Bohannon, T.E. Toliver-Kinsky, Y. Guo, and E.R. Sherwood. 2014. The role of CXCL10 in the pathogenesis of experimental septic shock. Critical Care 18 (3): R113. https://doi.org/10.1186/cc13902.CrossRefPubMedPubMedCentral

22.

Wang, M., Q. Zhang, X. Zhao, G. Dong, and C. Li. 2014. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the emergency department: an observational study. Critical Care 18 (6): 634. https://doi.org/10.1186/s13054-014-0634-6.CrossRefPubMedPubMedCentral

23.

Rahman, M., S. Zhang, M. Chew, I. Syk, B. Jeppsson, and H. Thorlacius. 2013. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. Journal of Thrombosis and Haemostasis 11 (7): 1385–1398. https://doi.org/10.1111/jth.12273.CrossRefPubMed

24.

Uwe, S. 2008. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks. Biochemical Pharmacology 75 (8): 1567–1579. https://doi.org/10.1016/j.bcp.2007.10.027.CrossRefPubMed

25.

Blackwell, T.S., F.E. Yull, C.L. Chen, A. Venkatakrishnan, T.R. Blackwell, D.J. Hicks, L.H. Lancaster, J.W. Christman, and L.D. Kerr. 2000. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. American Journal of Respiratory and Critical Care Medicine 162 (3 Pt 1): 1095–1101. https://doi.org/10.1164/ajrccm.162.3.9906129.CrossRefPubMed

26.

Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132 (3): 344–362. https://doi.org/10.1016/j.cell.2008.01.020.CrossRefPubMed

27.

Arthur, J.S., and S.C. Ley. 2013. Mitogen-activated protein kinases in innate immunity. Nature Reviews. Immunology 13 (9): 679–692. https://doi.org/10.1038/nri3495.CrossRefPubMed

28.

Pizzino, G., A. Bitto, G. Pallio, N. Irrera, F. Galfo, M. Interdonato, A. Mecchio, F. de Luca, L. Minutoli, F. Squadrito, and D. Altavilla. 2015. Blockade of the JNK signalling as a rational therapeutic approach to modulate the early and late steps of the inflammatory cascade in polymicrobial sepsis. Mediators of Inflammation 2015: 591572. https://doi.org/10.1155/2015/591572.CrossRefPubMedPubMedCentral

29.

Zhao, J., H. Yu, Y. Liu, S.A. Gibson, Z. Yan, X. Xu, A. Gaggar, P.K. Li, C. Li, S. Wei, E.N. Benveniste, and H. Qin. 2016. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 311 (5): L868–L880. https://doi.org/10.1152/ajplung.00281.2016.CrossRefPubMedPubMedCentral

30.

Severgnini, M., S. Takahashi, L.M. Rozo, R.J. Homer, C. Kuhn, J.W. Jhung, G. Perides, M. Steer, P.M. Hassoun, B.L. Fanburg, B.H. Cochran, and A.R. Simon. 2004. Activation of the STAT pathway in acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 286 (6): L1282–L1292. https://doi.org/10.1152/ajplung.00349.2003.CrossRefPubMed

31.

Song, Z., X. Zhao, Y. Gao, M. Liu, M. Hou, H. Jin, and Y. Cui. 2015. Recombinant human brain natriuretic peptide ameliorates trauma-induced acute lung injury via inhibiting JAK/STAT signaling pathway in rats. Journal of Trauma and Acute Care Surgery 78 (5): 980–987. https://doi.org/10.1097/TA.0000000000000602.CrossRefPubMed

Titel: Inhibition of Fibroblast Growth Factor Receptor by AZD4547 Protects Against Inflammation in Septic Mice
verfasst von: Yueyue Huang
Fen Wang
Hao Li
ShunYao Xu
Wenwei Xu
XiaoJun Pan
Yufeng Hu
Lingjie Mao
Songzan Qian
Jingye Pan
Publikationsdatum: 18.07.2019
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 6/2019
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-019-01056-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Inhibition of Fibroblast Growth Factor Receptor by AZD4547 Protects Against Inflammation in Septic Mice

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Pleural Effusion IL-33/sST2 Levels and Effects of Low and High IL-33/sST2 Levels on Human Mesothelial Cell Adhesion and Migration

MMP-9 Inhibition Suppresses Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells

Investigation of Extracellular Matrix Protein Expression Dynamics Using Murine Models of Systemic Inflammation

Catalase S-Glutathionylation by NOX2 and Mitochondrial-Derived ROS Adversely Affects Mice and Human Neutrophil Survival

Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model

Inhibition of NADPH Oxidase-Derived Reactive Oxygen Species Decreases Expression of Inflammatory Cytokines in A549 Cells

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin